The pause on the use of the Johnson & Johnson vaccine will continue as a federal panel reviews the cases of six women who received the vaccine and developed blood clots.
The pause on the use of the Johnson & Johnson vaccine will continue as a federal panel reviews the cases of six women who received the vaccine and developed blood clots.